MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
25.24
-0.01
-0.04%
Opening 09:39 08/13 EDT
OPEN
25.54
PREV CLOSE
25.25
HIGH
25.54
LOW
25.05
VOLUME
30.98K
TURNOVER
--
52 WEEK HIGH
26.16
52 WEEK LOW
11.92
MARKET CAP
4.03B
P/E (TTM)
-61.8779
1D
5D
1M
3M
1Y
5Y
1D
Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales
Simply Wall St · 8h ago
Why Did Adaptive Biotechnologies (ADPT) Move After Its Latest Update?
Simply Wall St · 2d ago
Weekly Report: what happened at ADPT last week (0803-0807)?
Weekly Report · 3d ago
Adaptive Biotechnologies (ADPT) Is Up 10.5% After Raising 2026 MRD Revenue Guidance Has The Bull Case Changed?
Simply Wall St · 3d ago
Adaptive Biotechnologies (ADPT) Stock Gains Little As MRD Growth Meets Wider Losses
Simply Wall St · 08/05 22:21
Is Adaptive Biotechnologies (ADPT) Fairly Valued After Its MRD Split Plan?
Simply Wall St · 08/04 20:32
Adaptive Biotechnologies (ADPT) Receives a Buy from Piper Sandler
TipRanks · 08/04 13:29
Adaptive Biotechnologies Is Maintained at Overweight by Piper Sandler
Dow Jones · 08/04 12:22
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company focuses on the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its technologies to read the genetic code of a patient's immune system. It operates through two segments, which include Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic testing service, offered to clinicians. Its Immune Medicine business focuses on immune-repertoire sequencing, target antigen discovery, data licensing and TCR-antigen prediction models in the identification, validation, development and adoption of products and services.

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.